Ghana FDA approves first locally manufactured oncology drug
The Food and Drugs Authority has granted marketing authorisation to the first oncology medication manufactured entirely in Ghana.
The Food and Drugs Authority (FDA) has granted full marketing authorisation to the first oncology medication manufactured entirely in Ghana, a landmark for the country's pharmaceutical manufacturing sector.
FDA CEO Delese Mimi Darko said the drug — an oral chemotherapy agent for chronic myeloid leukaemia — had passed rigorous quality testing equivalent to international standards.
The manufacturer, Kinapharma Limited, invested over $12 million in upgrading its Accra facility to WHO GMP standards.
Related stories
Health
Next-Generation TB Vaccines Could Save 7.3 Million Lives by 2050, Says Gavi
New tuberculosis vaccines expected to reach the market from 2029 could save an estimated 7.3 million lives and generate up to $135 billion in economic benefits for low- and middle-income countries by 2050, ending more than a century of reliance on a single licensed TB vaccine.
Health
WHO Warns of Hidden Mpox Spread in Africa
The WHO reports 1,153 new mpox cases and 7 deaths across 11 African countries in a six-week period, with Madagascar recording the highest burden amid surveillance challenges
Health
UCH Ibadan Health Workers Begin Indefinite Strike Over Unpaid Wages
Health workers at the University College Hospital (UCH), Ibadan, have embarked on an indefinite strike over unpaid salaries, allowances, and poor working conditions, paralysing services at Nigeria's foremost teaching hospital. The strike, declared after the expiration of a 21-day ultimatum to the hospital management and the Federal Government, has left thousands of patients stranded and raised fresh concerns about the collapse of tertiary healthcare in the country.
Health
WHO Sounds Alarm as NCDs Now Cause 37% of Deaths in Africa
The World Health Organization has issued a stark warning that non-communicable diseases now account for 37 per cent of all deaths in Africa, up from 24 per cent in 2000, with nearly two-thirds of these deaths occurring prematurely. As World Patient Safety Day 2026 focuses on "Safe Care for Noncommunicable Diseases," WHO Regional Director for Africa Dr. Mohammed Janabi has called for urgent action to protect millions of patients from avoidable harm during long-term treatment.
Comments (0)
Leave a comment
All comments are moderated before publishing. Your email is never published.